Cargando…

Solid and Suspension Microarrays for Microbial Diagnostics

Advancements in molecular technologies have provided new platforms that are being increasingly adopted for use in the clinical microbiology laboratory. Among these, microarray methods are particularly well suited for diagnostics as they allow multiplexing, or the ability to test for multiple targets...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Steve, Karaoz, Ulas, Brodie, Eoin, Dunbar, Sherry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172482/
http://dx.doi.org/10.1016/bs.mim.2015.04.002
_version_ 1783524266196598784
author Miller, Steve
Karaoz, Ulas
Brodie, Eoin
Dunbar, Sherry
author_facet Miller, Steve
Karaoz, Ulas
Brodie, Eoin
Dunbar, Sherry
author_sort Miller, Steve
collection PubMed
description Advancements in molecular technologies have provided new platforms that are being increasingly adopted for use in the clinical microbiology laboratory. Among these, microarray methods are particularly well suited for diagnostics as they allow multiplexing, or the ability to test for multiple targets simultaneously from the same specimen. Microarray technologies commonly used for the detection and identification of microbial targets include solid-state microarrays, electronic microarrays and bead suspension microarrays. Microarray methods have been applied to microbial detection, genotyping and antimicrobial resistance gene detection. Microarrays can offer a panel approach to diagnose specific patient presentations, such as respiratory or gastrointestinal infections, and can discriminate isolates by genotype for tracking epidemiology and outbreak investigations. And, as more information has become available on specific genes and pathways involved in antimicrobial resistance, we are beginning to be able to predict susceptibility patterns based on sequence detection for particular organisms. With further advances in automated microarray processing methods and genotype–phenotype prediction algorithms, these tests will become even more useful as an adjunct or replacement for conventional antimicrobial susceptibility testing, allowing for more rapid selection of targeted therapy for infectious diseases.
format Online
Article
Text
id pubmed-7172482
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71724822020-04-22 Solid and Suspension Microarrays for Microbial Diagnostics Miller, Steve Karaoz, Ulas Brodie, Eoin Dunbar, Sherry Methods in Microbiology Article Advancements in molecular technologies have provided new platforms that are being increasingly adopted for use in the clinical microbiology laboratory. Among these, microarray methods are particularly well suited for diagnostics as they allow multiplexing, or the ability to test for multiple targets simultaneously from the same specimen. Microarray technologies commonly used for the detection and identification of microbial targets include solid-state microarrays, electronic microarrays and bead suspension microarrays. Microarray methods have been applied to microbial detection, genotyping and antimicrobial resistance gene detection. Microarrays can offer a panel approach to diagnose specific patient presentations, such as respiratory or gastrointestinal infections, and can discriminate isolates by genotype for tracking epidemiology and outbreak investigations. And, as more information has become available on specific genes and pathways involved in antimicrobial resistance, we are beginning to be able to predict susceptibility patterns based on sequence detection for particular organisms. With further advances in automated microarray processing methods and genotype–phenotype prediction algorithms, these tests will become even more useful as an adjunct or replacement for conventional antimicrobial susceptibility testing, allowing for more rapid selection of targeted therapy for infectious diseases. Elsevier Ltd. 2015 2015-05-14 /pmc/articles/PMC7172482/ http://dx.doi.org/10.1016/bs.mim.2015.04.002 Text en Copyright © 2015 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Miller, Steve
Karaoz, Ulas
Brodie, Eoin
Dunbar, Sherry
Solid and Suspension Microarrays for Microbial Diagnostics
title Solid and Suspension Microarrays for Microbial Diagnostics
title_full Solid and Suspension Microarrays for Microbial Diagnostics
title_fullStr Solid and Suspension Microarrays for Microbial Diagnostics
title_full_unstemmed Solid and Suspension Microarrays for Microbial Diagnostics
title_short Solid and Suspension Microarrays for Microbial Diagnostics
title_sort solid and suspension microarrays for microbial diagnostics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172482/
http://dx.doi.org/10.1016/bs.mim.2015.04.002
work_keys_str_mv AT millersteve solidandsuspensionmicroarraysformicrobialdiagnostics
AT karaozulas solidandsuspensionmicroarraysformicrobialdiagnostics
AT brodieeoin solidandsuspensionmicroarraysformicrobialdiagnostics
AT dunbarsherry solidandsuspensionmicroarraysformicrobialdiagnostics